282 studies found for:    CSF1R
Show Display Options
Rank Status Study
1 Recruiting A Study of IMC-CS4 in Subjects With Advanced Solid Tumors
Condition: Neoplasms
Intervention: Biological: IMC-CS4
2 Completed A Study of ARRY-382 in Patients With Selected Advanced or Metastatic Cancers
Condition: Metastatic Cancer
Intervention: Drug: ARRY-382, cFMS inhibitor; oral
3 Active, not recruiting Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis
Conditions: Uterine Neoplasms;   Endometrial Neoplasms
Intervention:
4 Completed To Assess the Interaction Between Sunitinib and Ketoconazole to Reduce the Dose and Cost of Sunitinib
Condition: Cancer
Interventions: Drug: Sunitinib;   Drug: Sunitinib and Ketoconazol;   Drug: Sunitiinb and Ketoconazol
5 Completed
Has Results
Dovitinib for Imatinib/Sumitinib-failed Gastrointestinal Stromal Tumors (GIST)
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: dovitinib
6 Recruiting Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: My Own Specific Treatment
Condition: Malignant Solid Neoplasms
Interventions: Drug: Nilotinib (400 mg BID);   Drug: Everolimus (10 mg QD);   Drug: Sorafenib (400 mg BID);   Drug: Lapatinib (1500 mg QD);   Drug: Pazopanib (800 mg QD)
7 Terminated CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma, Non-Hodgkin;   Lymphoma, B-Cell;   Lymphoma, Diffuse
Interventions: Drug: GM-CSF;   Drug: CHOP;   Drug: Rituximab
8 Terminated Open-label Trial of Leukine in Active Crohn's Disease
Condition: Crohn Disease
Intervention: Drug: Sargramostim (Leukine)
9 Recruiting A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
Condition: Prostate Cancer Metastatic
Interventions: Biological: PROSTVAC-V;   Biological: PROSTVAC-F;   Drug: GM-CSF;   Other: GM-CSF Placebo;   Biological: Placebo
10 Not yet recruiting Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection
Conditions: Acute HIV Infection;   HIV Infections
Intervention: Drug: Telmisartan
11 Recruiting Therapy for Children With Advanced Stage Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: cyclophosphamide;   Drug: topotecan;   Biological: hu14.18K322A;   Procedure: peripheral blood stem cell harvest;   Procedure: surgical resection;   Drug: cisplatin;   Drug: etoposide;   Drug: doxorubicin;   Drug: vincristine;   Drug: busulfan;   Drug: melphalan;   Biological: peripheral blood stem cell transplantation;   Biological: natural killer cell infusion;   Radiation: radiation therapy;   Biological: GM-CSF;   Biological: G-CSF;   Drug: mesna;   Drug: levetiracetam;   Biological: interleukin-2;   Drug: Isotretinoin
12 Active, not recruiting Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
Conditions: Glioblastoma;   Small Cell Glioblastoma;   Giant Cell Glioblastoma;   Gliosarcoma;   Glioblastoma With Oligodendroglial Component
Interventions: Drug: Rindopepimut (CDX-110) with GM-CSF;   Drug: Temozolomide;   Drug: KLH
13 Completed Combination Chemotherapy in Treating Children With Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Biological: sargramostim;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
14 Terminated Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease
Condition: Crohn Disease
Interventions: Drug: Sargramostim (Leukine);   Drug: Placebo
15 Completed Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease
Condition: Crohn Disease
Interventions: Drug: Sargramostim (Leukine);   Drug: Placebo
16 Completed Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Conditions: Head and Neck Cancer;   Oral Complications;   Radiation Toxicity
Interventions: Biological: sargramostim;   Procedure: quality-of-life assessment;   Radiation: radiation therapy
17 Recruiting A Study of Improving the Efficacy of Treatment in Diffused Large B Cell Lymphoma Patients
Condition: Diffuse Large B-cell Lymphoma
Intervention:
18 Unknown  GM-CSF in Patients With Pulmonary Alveolar Proteinosis
Condition: Pulmonary Alveolar Proteinosis
Intervention: Drug: GM-CSF (granulocyte-macrophage colony-stimulating factor, sargramostim)
19 Completed Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases
Conditions: Chronic Myeloproliferative Disorders;   Graft Versus Host Disease;   Leukemia;   Lymphoma;   Myelodysplastic Syndromes;   Secondary Myelofibrosis
Interventions: Biological: filgrastim;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
20 Unknown  Thalidomide for Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Thalidomide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years